| William J Riley, MD | |
|
1 Perkins Sq, Akron, OH 44308-1063 | |
| (330) 543-3276 | |
| (330) 543-8489 |
| Full Name | William J Riley |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Endocrinology |
| Location | 1 Perkins Sq, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043396484 | NPI | - | NPPES |
| T0176756 | Other | TX | TPI |
| 0895107 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0205X | Pediatrics - Pediatric Endocrinology | J5527 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William J Riley, MD 301 University Blvd, Galveston, TX 77555-5302 Ph: (409) 772-3365 | William J Riley, MD 1 Perkins Sq, Akron, OH 44308-1063 Ph: (330) 543-3276 |
News Archive
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM.
A team of medical ethics and public health experts say tough isolation measures, involuntary if need be, are justified to contain a deadly, contagious, drug-resistant strain of TB in South Africa and to prevent "a potentially explosive international health crisis."
Surgeons at the University of Illinois Medical Center at Chicago performed a groundbreaking robotic pancreatectomy in a 39-year-old man to relieve him of debilitating pain.
A novel study reveals that more than half of liver transplant patients want to be informed of donor risk at the time a liver is offered for transplantation. Nearly 80% of those patients want to be involved in the decision of whether or not to accept the organ according to findings published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today that their lead program, SBC-102, an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, currently in clinical trials, has been granted fast track designation by the U.S. Food and Drug Administration (FDA).
› Verified 3 days ago
Katrina Regula, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 White Pond Dr Ste 100, Akron, OH 44320 Phone: 330-865-1252 Fax: 330-865-1260 | |
Dr. Hiba Khankan, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8178 Fax: 330-543-8157 | |
Amanda Gogol-tagliaferro, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 215 W Bowery St, Akron, OH 44308 Phone: 330-543-8530 Fax: 330-543-3731 | |
Laura Discenna, Pediatrics Medicare: Medicare Enrolled Practice Location: 1463 Canton Rd, Akron, OH 44312 Phone: 330-253-4931 Fax: 330-253-8619 | |
Michael L. Bowman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8004 | |
Sarah E Kline Krammes, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-1000 | |
Vanisha Patel, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Third Floor, Akron, OH 44308 Phone: 330-543-5191 |